Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study
Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
The goal of treatment in patients with pulmonary arterial hypertension is to achieve a low risk status, indicating a favorable long-term outcome. The REPLACE study investigated the efficacy of switching to riociguat in patients with pulmonary arterial hypertension and an insufficient response to phosphodiesterase-5 inhibitors. In this post hoc anal...
Alternative Titles
Full title
Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_08adb177c61d4bc5bda85b40834655e2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_08adb177c61d4bc5bda85b40834655e2
Other Identifiers
ISSN
2045-8940,2045-8932
E-ISSN
2045-8940
DOI
10.1177/2045894020973124
